Cognitive profile as a predictor of the long-term outcome after deep brain stimulation in Parkinson's disease
Introduction
Patients with Parkinson's disease (PD) develop advanced motor symptoms including motor fluctuation and levodopa-induced dyskinesia as the diseases progresses. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidus interna (GPi) has become a standard treatment for these motor complications [1,2].
Historically, overt dementia has been considered to be a contraindication for DBS in PD [3,4]. However, there is scant scientific evidence to support this contraindication. Moreover, performing DBS procedures in PD patients with mild dementia who are still capable of providing informed consent is being debated because the patient may benefit ‘motorically’ from surgery despite the presence of dementia [5]. For these reasons, some patients with PD with medically intractable motor symptoms and mild dementia were treated with DBS in the real-world, under the circumstance that the patients and caregivers fully understand the disease status [5].
Since the candidates for DBS are mostly in the advanced stage of PD, the severity and pattern of cognitive impairment are highly heterogenous, involving all major cognitive domains to various degrees [6]. Although a substantial number of patients have PD with mild cognitive impairment (PD-MCI) at the time of surgery, which is considered as a transitional stage from PD with normal cognition (PD-NC) to PD with dementia (PDD), little is known about the risk of MCI itself on the outcome of DBS. Moreover, the ability of the characteristics of domain-specific cognitive impairment in non-demented patients predict the outcomes after DBS surgery remains underexplored.
This study aimed to investigate the effect of baseline cognitive profiles, including PDD, PD-MCI, and PD-NC on the long-term outcomes of DBS surgery, while comparing key outcome measures. Moreover, we further estimated whether impairment of a specific cognitive domain could predict the outcome in DBS recipients without dementia.
Section snippets
Participants
We retrospectively reviewed the electronic medical records of patients with PD who underwent STN or GPi DBS surgery at a single tertiary medical center from March 2002 to December 2017. Patients were excluded if: i) the diagnosis changed postoperatively to atypical Parkinsonism, ii) a serious adverse event was caused by the DBS itself, iii) DBS lead revision or removal were performed, and iv) they had not undergone standardized neuropsychological evaluation prior to surgery (Fig. 1). Patients
Results
From March 2002 to December 2017, 304 patients with PD who had undergone DBS for the GPi or STN were included in the final analysis. Fifteen patients underwent DBS surgery during early PDD, 210 during the PD-MCI stage, and 79 patients were PD-NC at the time of surgery (Fig. 1). The median follow-up duration was 4.0 years (interquartile range 3.0–6.0 years). The baseline characteristics are described in Table 1. No differences were observed in the baseline clinical characteristics among the
Discussion
The present study found that patients with PDD at baseline before DBS surgery substantially increased the risk of nursing home admission and progression to a bed-ridden state after DBS surgery compared with patients without dementia. However, patients with PD-MCI at baseline did not have a higher risk compared with those with PD-NC at baseline in any of the outcome variables. Visuospatial impairment was predictive of 3 of 4 key outcome measures (nursing home admission, progression to HY stage
Declarations of Competing Interest
None.
Acknowledgements
This study was supported by a grant from the Korea Healthcare Technology R & D Project, Ministry of Health & Welfare, Republic of Korea (HI19C0256). We appreciate the clinical psychologists who supported the study.
References (28)
- et al.
Cognitive impairment in patients with Parkinson's disease: Diagnosis, biomarkers, and treatment
Lancet Neurol.
(2012) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
J. Chronic Dis.
(1987) - et al.
Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: A meta-analysis
Lancet. Neurol.
(2006) - et al.
The cholinergic system and Parkinson disease
Behav. Brain Res.
(2011) - et al.
Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease
Parkinsonism Relat. Disord.
(2015) - et al.
The SCOPA-Motor Scale for assessment of Parkinson's disease is a consistent and valid measure
J. Clin. Epidemiol.
(2005) - et al.
International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
Move. Disorders Off. J. Move. Disorder Soc.
(2018) - et al.
Globus Pallidus Interna or subthalamic nucleus deep brain stimulation for Parkinson disease: A review
JAMA Neurol.
(2018) - et al.
Deep Brain Stimulation in Movement Disorders, Continuum (Minneapolis, Minn.) 16(1 Movement Disorders)
(2010) - et al.
Development and initial validation of a screening tool for Parkinson disease surgical candidates
Neurology
(2004)
Can deep brain stimulation be a therapeutic option for Parkinson's disease dementia?
Neurol. Clin. Neurosci.
Clinical characteristics in early Parkinson's disease in a Central California population-based study
Move. Disorders Off. J. Move. Disorder Soc.
Seoul neuropsychological screening battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients
J. Korean Med. Sci.
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Move. Disorders Off. J. Move. Disorder Soc.
Cited by (10)
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease
2024, Movement Disorders Clinical PracticePatients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case-Control Study
2023, Movement Disorders Clinical PracticeMini-Mental State Examination predicts mortality in patients on chronic hemodialysis
2023, Seminars in DialysisShort and Long-Term Cognitive Effects of Subthalamic Deep Brain Stimulation in Parkinson's Disease and Identification of Relevant Factors
2022, Journal of Parkinson's Disease